Impact of COVID-19 on Cancer Care Management

Study Information

Locations

Not Specified

Clinical Trial FAQs

Information for patients and study volunteers, including frequently asked questions.

Description

Our project will enhance understanding of how cancer care is triaged, delivered, and how treatment plans are modified due to the impact of COVID-19.

Our project will inform the use of telemedicine in cancer care and variability by patient characteristics, which have the potential to reduce disparities in the delivery of telemedicine.

Our estimates on the volume of postponed services during COVID-19 pandemic can inform healthcare systems’ planning of future workflows as well as future studies evaluating the impact of delayed services on patient health outcomes.

John K. Chan, M.D., and Allison W. Kurian, M.D., MSc, are Clinical Advisors.

Principal Investigator

Su-Ying Liang, Ph.D.

Co-Investigator(s)

Monique de Bruin, M.D., MPH

Funder

UC Office of the President, Research Grants Program Office

Related Studies

COVID-19 Impacts on Cancer Care Management, Patient Experience and Care Costs

Project goals: To understand impacts of COVID-19 on cancer care management (detection, diagnosis, treatment), pt-reported experience, and cancer care costs.

Investigators: Cheryl Stults, Ph.D., Monique de Bruin, M.D., MPH, Su-Ying Liang, Ph.D.

The Impact of Smoking, Comorbidities, and Race/Ethnicity on COVID-19 Infection and Disease Severity

Using EHR from a large healthcare system in Northern CA, we will study the impact of smoking, comorbidities, race on COVID-19 infection and disease severity.

Investigator: Jiang Li, Ph.D., MPH

Statin Use and Risk Prediction of Atherosclerotic Cardiovascular Disease in Minority Subgroups (SURPASS) Study

Overall goal of this study is to address gaps in knowledge about CVD prediction and treatment in understudied racial/ethnic minority populations.

Investigators: Jiang Li, Ph.D., MPH, External PI, Principal Investigator

Lung Cancer in Never Smokers: Incidence, Risk Factors and Molecular Characteristics in Asian American, Native Hawaiian, and Pacific Islander (AANHPI) Women

The goal of this project is to document incidence and risk factors for lung cancer by smoking status, among AANHPIs, focusing especially on female never smokers.

Investigators: Su-Ying Liang, Ph.D., External PI, Principal Investigator

Impact of COVID-19 on Cancer Care Management

Study Information

Locations

Clinical Trial FAQs

Description

Principal Investigator

Co-Investigator(s)

Funder

Related Studies

COVID-19 Impacts on Cancer Care Management, Patient Experience and Care Costs

The Impact of Smoking, Comorbidities, and Race/Ethnicity on COVID-19 Infection and Disease Severity

Statin Use and Risk Prediction of Atherosclerotic Cardiovascular Disease in Minority Subgroups (SURPASS) Study

Lung Cancer in Never Smokers: Incidence, Risk Factors and Molecular Characteristics in Asian American, Native Hawaiian, and Pacific Islander (AANHPI) Women

Understanding the Needs and Experiences of High Utilizers at the Emergency Department of Highland Hospital

Understanding Non-clinical Determinants of Long-term Hospital Stays Among High Utilizing Patients at ABSMC

Prevalence, Treatment and Outcomes of Asian Subgroups with Coronary Artery Disease in the U.S.

Medication Adherence and Patient Satisfaction With Provider Communication Difference Across Diverse Racial/Ethnic Groups

Cardiovascular Disease Among Asians and Pacific Islanders (CASPER)

A Patient-Centered Strategy for Improving Diabetes Prevention in Urban American Indians.